O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/2/2020ACC: 0001209191-20-049095
Officer· Chief Medical Officer
Since Jun 2018
+138.00
Net shares
Net buyer
$947.37
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
138.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+69.00
Price / share
$13.73
Trade value
$947.37
% of position
3.2%
8/31/2020
2.16K→2.23K
Total
Net shares
+69.00
Net value
$947.37
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/31/2020 | A · Award | +69.00 | $13.73 | $947.37 | 3.2% | 2.16K | 2.23K |
| Total | +69.00 | $947.37 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
69.00 shares
Shares
+69.00
Strike price
16.15
Held after
69.00
Exercisable
—
8/31/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock69.00 shares | 8/31/2020 | A · Award | +69.00 | 16.15 | — | 69.00 |